EIDOS THERAPEUTICS, INC. Proceeds from Issuance Initial Public Offering
EIDOS THERAPEUTICS, INC. reported Proceeds from Issuance Initial Public Offering of $110.97 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-02-26
- EIDOS THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2018-12-31 was $0.00.
- EIDOS THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2018-09-30 was -$1.19M.
- EIDOS THERAPEUTICS, INC. proceeds from issuance initial public offering for fiscal 2018 was $110.97M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$1.19M derived: sum of 2 quarters · filed 2020-02-26 | $110.97M 10-K · filed 2020-02-26 | |
| 2018-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $110.97M 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $112.16M 10-Q · filed 2019-08-01 |